Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 198.50
-2.50 (-1.24%)
Jun 5, 2026, 1:30 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 52.82 billion as of June 5, 2026. Its market cap has decreased by -12.01% in one year.
Market Cap
52.82B
Enterprise Value
94.63B
Revenue
24.42B
Ranking
n/a
PE Ratio
13.61
Stock Price
198.50
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 52.82B, an increase of 474.97%. That is a compound annual growth rate of 15.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 52.82B | -29.02% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 335.21B |
| Bora Pharmaceuticals | 45.27B |
| Center Laboratories | 28.67B |
| TTY Biopharm Company | 18.33B |
| ScinoPharm Taiwan | 15.58B |
| Synmosa Biopharma | 15.16B |
| YungShin Global Holding | 15.00B |
| Grape King Bio | 14.89B |